페티딘 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "페티딘" in Korean language version.

refsWebsite

Global rank Korean rank

7doi.org

2^nd place

3^rd place

7nih.gov

4^th place

2web.archive.org

1^st place

1medscape.com

719^th place

424^th place

1nzma.org.nz

low place

1wikipedia.org

low place

1shpa.org.au

low place

doi.org

dx.doi.org

Ngan Kee, WD (April 1998). “Intrathecal pethidine: pharmacology and clinical applications.”. 《Anaesthesia and Intensive Care》 26 (2): 137–46. doi:10.1177/0310057X9802600202. PMID 9564390.
Ngan Kee, WD (June 1998). “Epidural pethidine: pharmacology and clinical experience.”. 《Anaesthesia and Intensive Care》 26 (3): 247–55. doi:10.1177/0310057X9802600303. PMID 9619217.
Latta, KS; Ginsberg, B; Barkin, RL (January–February 2002). “Meperidine: a critical review.”. 《en:American Journal of Therapeutics》 9 (1): 53–68. doi:10.1097/00045391-200201000-00010. PMID 11782820.
MacPherson RD, Duguid MD (2008). “Strategy to Eliminate Pethidine Use in Hospitals” (PDF). 《Journal of Pharmacy Practice and Research》 38 (2): 88–89. doi:10.1002/j.2055-2335.2008.tb00807.x. 2014년 2월 15일에 원본 문서 (PDF)에서 보존된 문서.
Mather, LE; Meffin, PJ (September–October 1978). “Clinical pharmacokinetics of pethidine.”. 《Clinical Pharmacokinetics》 3 (5): 352–68. doi:10.2165/00003088-197803050-00002. PMID 359212.
Michaelis, Martin; Schölkens, Bernward; Rudolphi, Karl (April 2007). “An anthology from Naunyn-Schmiedeberg's Archives of Pharmacology”. 《Naunyn-Schmiedeberg's Archives of Pharmacology》 375 (2): 81–84. doi:10.1007/s00210-007-0136-z. PMID 17310263.
Kaiko, Robert F.; Kathleen M. Foley; Patricia Y. Grabinski; George Heidrich; Ada G. Rogers; Charles E. Inturrisi; Marcus M. Reidenberg (February 1983). “Central Nervous System Excitatory Effects of Meperidine in Cancer Patients”. 《Annals of Neurology》 13 (2): 180–185. doi:10.1002/ana.410130213. PMID 6187275.

medscape.com

reference.medscape.com

“Demerol, Pethidine (meperidine) dosing, indications, interactions, adverse effects, and more”. 《Medscape Reference》. WebMD. 2014년 4월 9일에 확인함.

nih.gov

ncbi.nlm.nih.gov

Ngan Kee, WD (April 1998). “Intrathecal pethidine: pharmacology and clinical applications.”. 《Anaesthesia and Intensive Care》 26 (2): 137–46. doi:10.1177/0310057X9802600202. PMID 9564390.
Ngan Kee, WD (June 1998). “Epidural pethidine: pharmacology and clinical experience.”. 《Anaesthesia and Intensive Care》 26 (3): 247–55. doi:10.1177/0310057X9802600303. PMID 9619217.
Shipton, E (March 2006). “Should New Zealand continue signing up to the Pethidine Protocol?” (PDF). 《The New Zealand Medical Journal》 119 (1230): U1875. PMID 16532042. 2014년 4월 8일에 원본 문서 (PDF)에서 보존된 문서.
Latta, KS; Ginsberg, B; Barkin, RL (January–February 2002). “Meperidine: a critical review.”. 《en:American Journal of Therapeutics》 9 (1): 53–68. doi:10.1097/00045391-200201000-00010. PMID 11782820.
Mather, LE; Meffin, PJ (September–October 1978). “Clinical pharmacokinetics of pethidine.”. 《Clinical Pharmacokinetics》 3 (5): 352–68. doi:10.2165/00003088-197803050-00002. PMID 359212.
Michaelis, Martin; Schölkens, Bernward; Rudolphi, Karl (April 2007). “An anthology from Naunyn-Schmiedeberg's Archives of Pharmacology”. 《Naunyn-Schmiedeberg's Archives of Pharmacology》 375 (2): 81–84. doi:10.1007/s00210-007-0136-z. PMID 17310263.
Kaiko, Robert F.; Kathleen M. Foley; Patricia Y. Grabinski; George Heidrich; Ada G. Rogers; Charles E. Inturrisi; Marcus M. Reidenberg (February 1983). “Central Nervous System Excitatory Effects of Meperidine in Cancer Patients”. 《Annals of Neurology》 13 (2): 180–185. doi:10.1002/ana.410130213. PMID 6187275.

nzma.org.nz

journal.nzma.org.nz

Shipton, E (March 2006). “Should New Zealand continue signing up to the Pethidine Protocol?” (PDF). 《The New Zealand Medical Journal》 119 (1230): U1875. PMID 16532042. 2014년 4월 8일에 원본 문서 (PDF)에서 보존된 문서.

shpa.org.au

jppr.shpa.org.au

MacPherson RD, Duguid MD (2008). “Strategy to Eliminate Pethidine Use in Hospitals” (PDF). 《Journal of Pharmacy Practice and Research》 38 (2): 88–89. doi:10.1002/j.2055-2335.2008.tb00807.x. 2014년 2월 15일에 원본 문서 (PDF)에서 보존된 문서.

web.archive.org

Shipton, E (March 2006). “Should New Zealand continue signing up to the Pethidine Protocol?” (PDF). 《The New Zealand Medical Journal》 119 (1230): U1875. PMID 16532042. 2014년 4월 8일에 원본 문서 (PDF)에서 보존된 문서.
MacPherson RD, Duguid MD (2008). “Strategy to Eliminate Pethidine Use in Hospitals” (PDF). 《Journal of Pharmacy Practice and Research》 38 (2): 88–89. doi:10.1002/j.2055-2335.2008.tb00807.x. 2014년 2월 15일에 원본 문서 (PDF)에서 보존된 문서.

wikipedia.org

en.wikipedia.org

Latta, KS; Ginsberg, B; Barkin, RL (January–February 2002). “Meperidine: a critical review.”. 《en:American Journal of Therapeutics》 9 (1): 53–68. doi:10.1097/00045391-200201000-00010. PMID 11782820.